Doctors are already using AI in care – but we don’t actually know what safe use should look like
A survey of 1,000 UK doctors found one in five used ChatGPT or Gemini in clinical practice.
Related Articles
Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research
Abstract. Precision oncology tailors treatment strategies to a patient’s molecular and health data. Despite the essential clinical value of current diagnostic methods, hematoxylin and eosin…
Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell Transplantation
Pure red cell aplasia (PRCA) is a rare but significant complication following major ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT). The persistence of recipient B…
CMS’s Medical Debt Relief Will Worsen Medical Debt
CMS’s debt relief approach, devoid of accountability to taxpayers and riddled with harmful incentives, will worsen medical debt. It’s time to focus on fixing root…
MCBGP Seminar Series: Graham Walker, PhD
MCB Graduate Program Seminar Graham Walker, PhD American Cancer Society Professor, HHMI Professor Massachusetts I…
High-Sensitivity and Conventional Cardiac Troponin-I Assays in AL Amyloidosis – PubMed
Overall agreement was demonstrated; however, a negative bias for HS-cTnI assay was noted at low concentrations. The application of the conventional cTnI threshold of >100…
Standing desks are bad for your health, according to new study
This article was originally featured on The Conversation.
Conformational differences in the light chain constant domain of immunoglobulin G and free light chain may influence proteolysis in AL amyloidosis – PubMed
Immunoglobulin light chain amyloidosis (AL) is a life-threatening disease caused by the deposition of light chain (LC) and its fragments containing variable (VL) and portions…
‘Ghost network’ of US healthcare providers amounts to fraud
New lawsuit finds ‘staggering’ cases of people struggling to find mental health care coinciding with mental health crisis
An old drug with new tricks: Exploring the cancer-fighting promise and limitations of hydroxychloroquine
As the hunt for effective cancer therapies intensifies, some scientists are turning back to look at old drugs in a new light. The anti-malarial hydroxychloroquine…